Antibody-drug conjugates and application method based on eribulin

• 收藏
• 分享

专利权人:

에자이 알앤드디 매니지먼트 가부시키가이샤

发明人:

알본, 얼, 에프.,청, 신,커스타, 다니엘, 더블유.,후루우치, 케이지,리, 징,메이줌더, 우트팔,우에나카, 토시미쓰

申请号：

KR1020187028407

公开号：

KR1020180115330A

申请日:

2017.03.02

申请国别(地区):

KR

年份:

2018

代理人:

摘要：

Linker toxin and antibody-drug conjugates combination human tumour antigen target, for example, folacin receptor α and/or provide for microtubulin-resisting pharmaceutical activity disclosure. Connector toxin and antibody-drug conjugates include eribulin pharmaceutical group and can internalization to target antigen expression cell. The disclosure is provided further to the method and composition for treating cancer by the way that the antibody-drug conjugates are administered herein.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/